摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(6S,9R,15S,18R)-methyl 9,18-diallyl-15-benzyl-6-(4-hydroxybenzyl)-2,2-dimethyl-4,7,10,13,16-pentaoxo-3-oxa-5,8,11,14,17-pentaazanonadecan-19-oate | 944918-33-6

中文名称
——
中文别名
——
英文名称
(6S,9R,15S,18R)-methyl 9,18-diallyl-15-benzyl-6-(4-hydroxybenzyl)-2,2-dimethyl-4,7,10,13,16-pentaoxo-3-oxa-5,8,11,14,17-pentaazanonadecan-19-oate
英文别名
Boc-Tyr-D-Gly(allyl)-Gly-Phe-D-Gly(allyl)-OMe;methyl (2R)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]pent-4-enoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]pent-4-enoate
(6S,9R,15S,18R)-methyl 9,18-diallyl-15-benzyl-6-(4-hydroxybenzyl)-2,2-dimethyl-4,7,10,13,16-pentaoxo-3-oxa-5,8,11,14,17-pentaazanonadecan-19-oate化学式
CAS
944918-33-6
化学式
C36H47N5O9
mdl
——
分子量
693.797
InChiKey
ITWRXBBYVUYPJK-GKQHHHCTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    50
  • 可旋转键数:
    21
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    201
  • 氢给体数:
    6
  • 氢受体数:
    9

反应信息

  • 作为反应物:
    描述:
    (6S,9R,15S,18R)-methyl 9,18-diallyl-15-benzyl-6-(4-hydroxybenzyl)-2,2-dimethyl-4,7,10,13,16-pentaoxo-3-oxa-5,8,11,14,17-pentaazanonadecan-19-oatesodium hydroxide 作用下, 以 甲醇 为溶剂, 反应 3.0h, 生成 N-tert-butyloxycarbonyl-L-tyrosinyl-D-allylglycyl-glycyl-L-phenylalanyl-D-allylglycine-OH
    参考文献:
    名称:
    Synthesis of Stable and Potent δ/μ Opioid Peptides:  Analogues of H-Tyr-c[d-Cys-Gly-Phe-d-Cys]-OH by Ring-Closing Metathesis
    摘要:
    Ring-closing metathesis has emerged as a powerful tool in organic synthesis for generating cyclic structures via C-C double bond formation. Recently, it has been successfully used in peptide chemistry for obtaining cyclic molecules bridged through an olefin unit in place of the usual disulfide bond. Here, we describe this approach for obtaining cyclic olefin bridged analogues of H-Tyr-c[D-Cys-Gly-Phe-Cys]-OH. The synthesis of the new ligands was performed using the second generation Grubbs' catalyst. The resulting cis-8 (cDADAE) and trans-9 (tDADAE) were fully characterized and tested at delta, mu, and kappa opioid receptors. Also the linear precursor 13 (lDADAE) and the hydrogenated derivative 11(rDADAE) also were tested. All the cyclic products containing a olefinic bond are slightly selective but highly active and potent for the delta and mu opioid receptors. Activity toward the kappa opioid receptors was absent or very low.
    DOI:
    10.1021/jm061048b
  • 作为产物:
    参考文献:
    名称:
    Synthesis of Stable and Potent δ/μ Opioid Peptides:  Analogues of H-Tyr-c[d-Cys-Gly-Phe-d-Cys]-OH by Ring-Closing Metathesis
    摘要:
    Ring-closing metathesis has emerged as a powerful tool in organic synthesis for generating cyclic structures via C-C double bond formation. Recently, it has been successfully used in peptide chemistry for obtaining cyclic molecules bridged through an olefin unit in place of the usual disulfide bond. Here, we describe this approach for obtaining cyclic olefin bridged analogues of H-Tyr-c[D-Cys-Gly-Phe-Cys]-OH. The synthesis of the new ligands was performed using the second generation Grubbs' catalyst. The resulting cis-8 (cDADAE) and trans-9 (tDADAE) were fully characterized and tested at delta, mu, and kappa opioid receptors. Also the linear precursor 13 (lDADAE) and the hydrogenated derivative 11(rDADAE) also were tested. All the cyclic products containing a olefinic bond are slightly selective but highly active and potent for the delta and mu opioid receptors. Activity toward the kappa opioid receptors was absent or very low.
    DOI:
    10.1021/jm061048b
点击查看最新优质反应信息

文献信息

  • In Situ Methylene Capping: A General Strategy for Efficient Stereoretentive Catalytic Olefin Metathesis. The Concept, Methodological Implications, and Applications to Synthesis of Biologically Active Compounds
    作者:Chaofan Xu、Xiao Shen、Amir H. Hoveyda
    DOI:10.1021/jacs.7b06552
    日期:2017.8.9
    catalyst-controlled stereoselective olefin metathesis considerably. By incorporation of commercially available Z-butene together with robust and readily accessible Ru-based dithiolate catalysts developed in these laboratories, a large variety of transformations can be made to proceed with terminal alkenes, without the need for a priori synthesis of a stereochemically defined disubstituted olefin. Reactions thus proceed
    原位亚甲基封端作为一种实用且广泛适用的策略被引入,可以显着扩大催化剂控制的立体选择性烯烃复分解的范围。通过将市售的 Z-丁烯与这些实验室开发的坚固且易于获得的基于 Ru 的二醇催化剂结合,可以进行多种转化以处理末端烯烃,而无需先验合成立体化学定义的双取代烯烃。因此,与使用其他基于 Ru、Mo 或 W 的配合物相比,反应以显着更高的效率和 Z 选择性进行。与含有羧酸、醛、烯丙醇、芳基烯烃、α取代基的烯烃交叉复分解,或氨基酸残基以 47-88% 的产率和 90:10 至 >98:2 的 Z:E 选择性生成所需产物。使用 70:30 Z-:E-丁烯混合物(原油裂解的副产品),转化同样有效且具有立体选择性。原位亚甲基封端策略与相同的儿茶酚醇配合物(无需催化剂修饰)一起进行闭环复分解反应,以 40-70% 的产率和 96:4-98 的产率生成 14 至 21 元环大环烯烃:2 Z:E 选择性;与
  • [EN] METHOD OF MAKING A CROSS METATHESIS PRODUCT<br/>[FR] PROCÉDÉ DE FABRICATION D'UN PRODUIT DE MÉTATHÈSE CROISÉE
    申请人:TRUSTEES BOSTON COLLEGE
    公开号:WO2019018773A1
    公开(公告)日:2019-01-24
    Method of making a cross metathesis product, the method comprising at least step (X) or step (Y): (X) reacting in a cross metathesis reaction a first compound comprising a terminal olefinic group with a second compound comprising a terminal olefinic group, wherein the first and the second compound may be identical or may be different from one another; or (Y) reacting in a ring-closing metathesis reaction two terminal olefinic groups which are comprised in a third compound; wherein the reacting in step (X) or step (Y) is performed in the presence of a ruthenium carbene complex comprising a [Ru=C]-moiety and an internal olefin.
    制备交叉甲醇酯产物的方法,该方法包括至少步骤(X)或步骤(Y):(X)在交叉甲醇酯反应中,将含有端烯基团的第一化合物与含有端烯基团的第二化合物反应,其中第一和第二化合物可以相同也可以不同;或(Y)在环闭合甲醇酯反应中,将包含在第三化合物中的两个端烯基团反应;在步骤(X)或步骤(Y)中的反应是在存在包含[Ru=C]-基团和内烯烃的卡宾配合物的情况下进行的。
  • METHOD OF MAKING A CROSS METATHESIS PRODUCT
    申请人:Trustees of Boston College
    公开号:US20200123197A1
    公开(公告)日:2020-04-23
    Method of making a cross metathesis product, the method comprising at least step (X) or step (Y): (X) reacting in a cross metathesis reaction a first compound comprising a terminal olefinic group with a second compound comprising a terminal olefinic group, wherein the first and the second compound may be identical or may be different from one another; or (Y) reacting in a ring-closing metathesis reaction two terminal olefinic groups which are comprised in a third compound; wherein the reacting in step (X) or step (Y) is performed in the presence of a ruthenium carbene complex comprising a [Ru═C]-moiety and an internal olefin.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸